期刊文献+

甲硝唑降血脂临床观察及唾液药物浓度监测 被引量:1

CLINICAL OBSERVATION OF MN IN TREATMENT OF HYPERLIPEMIA AND ITS SALIVA DRUG CONCENTRATION MONITORING
下载PDF
导出
摘要 目的:评价甲硝唑降血脂疗效及唾液甲硝唑浓度监测。方法:23例高血脂症采用口服甲硝唑三种给药方案治疗:Ⅰ.06gtid×10d,n=6。Ⅱ.04gtid×10d,n=10。Ⅲ.02gtid×10d,n=7。结果:三种方案甘油三酯下降总有效率为667%,600%及428%;胆固醇下降总有效率为667%,600%及428%。三种方案治疗后血脂下降百分数为:甘油三酯为623%,346%及310%;胆固醇为304%,175%及194%。唾液中甲硝唑Cs三种方案依次为3139,2060及1620μg/ml。结论:甲硝唑降甘油三酯和胆固醇作用快速、明显。甲硝唑唾液浓度监测CSS有剂量依赖性,符合药物动力学规律。 Objective: To evaluation of MN in treatment of hypenlipemia and its saliva drug concentration monitoring. Methods:23 hyperlipemia patients were treated by Metronidazole (MN)orally. Three MN dosage schemes were administrated:(Ⅰ)0 6g tid ×10d,n=6;(Ⅱ)0 4g tid ×10d,n=10;(Ⅲ)0 2g tid×10d,n=7.Results:After 10 days MN therapy, the total curative rates of three schemes for triglyceride were 66.7%,60.0% and 42.8%, for cholesterol were 66.7%,60.0% and 42.8%. The decrease % of serum lipids of three schemes for triglyceride were 62.3%,34.6% and 31.0%, for cholesterol 30.4%,17.5% and 19.4%. The MN saliva C ss of three schemes were 31.39, 20.60 and 16.20 μg/ml.Conclusion: The function of MN bringing down triglyceride and cholesterol is quick and obvious. MN has the dependence on the dosage in determining C ss in salivary concentration.
出处 《内蒙古医学院学报》 1999年第1期25-27,共3页 Acta Academiae Medicinae Neimongol
基金 内蒙古自然科学基金
关键词 甲硝唑 血症过多 甘油三酯 胆固醇 唾液浓度 metronidazole hyperlipemia triglyceride, cholesterol salivary concentration
  • 相关文献

参考文献3

  • 1何家生.甲硝唑降血脂临床观察[J].新药与临床,1985,4(6):11-11.
  • 2魏征岩,王锡芳,王继栓,德曹明,宋芝香.甲硝唑治疗高脂血症的疗效观察[J].临床荟萃,1990,5(1):17-18. 被引量:8
  • 3卫生部心血管系统药物临床药理基地.心血管系统药物临床指导原则[J].中国临床药理学杂志,1998,14(4):245-247.

二级参考文献1

  • 1何家生,张希亚,唐澄清.甲硝唑降血脂临床观察[J]新药与临床,1985(06).

共引文献10

同被引文献15

  • 1陈燕,石涛,柳晓泉,钟皎,王广基.左旋和右旋奥硝唑在大鼠体内的药代动力学[J].中国药科大学学报,2006,37(1):41-44. 被引量:14
  • 2吴霞,刘洪臣,刘宇,鄂玲玲,王东胜,吕燕.大鼠下颌骨来源的成骨细胞对甲硝唑和替硝唑的转运[J].口腔颌面修复学杂志,2007,8(1):59-62. 被引量:23
  • 3冷斌,刘洪臣,鄂玲玲,刘宇,吴霞,吕燕.人牙龈成纤维细胞对甲硝唑的跨膜转运[J].中华老年口腔医学杂志,2007,5(2):100-103. 被引量:13
  • 4曹采方.牙周病学[M].北京:人民卫生出版社,2001.42-45.
  • 5楼雅卿.临床药代动力学-基础与应用[M].郑州:郑州大学出版社,2003:162-163.
  • 6Liew V, Mack G, Tseng P, et al. Single-dose concentrations of tinidazole in gingival crevicular fluid, serum, and gingival tissue in adults with periodontitis[J]. J Dent Res, 1991,70(5): 910-912
  • 7Debra Kalman, Steven L, Barriere, B, et al. Pharmacokinetic disposition and bactericidal activities of cefepime, ceftazidime, and cefoperazone in serum and blister fluid[J]. Antimicrobial agents and chemotherapy, 1992, 36 (2): 453-457
  • 8Craig WA, Kunin CM. Significance of serum protein and tissue binding of antimicrobial agents [J]. Annu Rev Med. 1976, 27.. 287-300
  • 9Haeckel R, Hanecke P. Application of saliva for drug monitoring. An in vivo model for transmembrane transport [J]. Eur J Clin Chem Clin Biochem, 1996, 34(3): 171-191
  • 10Lamp KC, Freeman CD, Klutman NE, et al. Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobial[J]. Clin Pharmacokinet, 1999, 36(5): 353-373

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部